REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
